Showing results (21-30 of 181) with videos related to
Sort By:
Pageof 19
International Journal of Molecular Sciences|May 28, 2019
Remarkable Alteration of PD-L1 Expression after Immune Checkpoint Therapy in Patients with Non-Small-Cell Lung Cancer: Two Autopsy Case ReportsToshiaki Takahashi, Akiko Tateishi, Andrey Bychkov, et al.Pathology|June 18, 2016
TROP-2 immunohistochemistry: a highly accurate method in the differential diagnosis of papillary thyroid carcinomaAndrey Bychkov, Pichet Sampatanukul, Shanop Shuangshoti, et al.Scientific Reports|July 14, 2017
PSMA expression by microvasculature of thyroid tumors - Potential implications for PSMA theranosticsAndrey Bychkov, Usanee Vutrapongwatana, Supatporn Tepmongkol, et al.Journal of Pathology and Translational Medicine|October 28, 2017
The Use of Fine-Needle Aspiration (FNA) Cytology in Patients with Thyroid Nodules in Asia: A Brief Overview of Studies from the Working Group of Asian Thyroid FNA CytologyChan Kwon Jung, SoonWon Hong, Andrey Bychkov, et al.Diagnostics (Basel, Switzerland)|April 3, 2021
High Expression of PD-L1 Is Associated with Better Survival in Pancreatic/Periampullary Cancers and Correlates with Epithelial to Mesenchymal TransitionNishant Thakur, Kwang Yeol Paik, Gyoyeon Hwang, et al.Endocrine Pathology|February 25, 2018
Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features in Asian Practice: Perspectives for Surgical Pathology and CytopathologyAndrey Bychkov, Chan Kwon Jung, Zhiyan Liu, et al.Gland Surgery|November 23, 2020
Prevalence of <i>BRAF</i> mutation in Asian series of papillary thyroid carcinoma-a contemporary systematic reviewFaiza Abdul Rashid, Jijgee Munkhdelger, Junya Fukuoka, et al.Cancers|March 11, 2020
VE1 Immunohistochemistry Improves the Limit of Genotyping for Detecting <i>BRAF</i><sup>V600E</sup> Mutation in Papillary Thyroid CancerSonam Choden, Somboon Keelawat, Chan Kwon Jung, et al.Gland Surgery|November 23, 2020
An affordable immunohistochemical approach to estimate the prevalence of <i>BRAF</i> in large cohort studies-establishing the baseline rate of <i>BRAF</i> mutation in an institutional series of papillary thyroid carcinoma from ThailandSonam Choden, Somboon Keelawat, Chan Kwon Jung, et al.Cancers|March 25, 2022
Tumor Budding in Gynecologic Cancer as a Marker for Poor Survival: A Systematic Review and Meta-Analysis of the Perspectives of Epithelial-Mesenchymal TransitionMuhammad Joan Ailia, Nishant Thakur, Yosep Chong, et al.Pageof 19